Nature Medicine Journal Issues Research Articles in July 2022 Edition
July 23, 2022
July 23, 2022
NEW YORK, July 23 -- Nature Medicine, a peer-reviewed journal on medicine, published research articles on the following topics in its July 2022 edition:
Articles:
* Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
* Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial
. . .
Articles:
* Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
* Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial
. . .